A case report: Clozapine‐induced leukopenia and neutropenia after mRNA COVID‐19 vaccination
Abstract Clozapine is an atypical antipsychotic used for treatment‐resistant schizophrenia and is known to cause serious side effects, such as leukopenia and neutropenia. We encountered the case of a 44‐year‐old female patient with a good response to clozapine, who experienced inflammatory reaction...
Main Authors: | Tomoyuki Imai, Sho Ochiai, Takehiro Ishimaru, Hayato Daitoku, Yusuke Miyagawa, Ryuji Fukuhara, Shuken Boku, Minoru Takebayashi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | Neuropsychopharmacology Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/npr2.12238 |
Similar Items
-
The effect of lithium on clozapine-induced neutropenia reduction in refractory schizoaffective disorder
by: Mehri Rezaei Kheirabadi, et al.
Published: (2023-10-01) -
The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia
by: Ebenezer Oloyede, et al.
Published: (2023-06-01) -
CLOZAPINE RECHALLENGE WITH LITHIUM AFTER DOUBLE INDUCED NEUTROPENIA: A CASE REPORT
by: A. Kourti, et al.
Published: (2019-01-01) -
Neutropenia in patients treated with clozapine during COVID-19 infection
by: J. Marti Bonany, et al.
Published: (2021-04-01) -
Neutropenia in patients under treatment with clozapine and COVID-19 infection
by: S. Bonaccorso, et al.
Published: (2021-04-01)